Sentence examples for cardiovascular interaction from inspiring English sources

49 To date, data from the only double-blinded randomized trial designed to address whether concomitant use of PPI with clopidogrel would adversely affect cardiovascular outcome did not find apparent cardiovascular interaction between clopidogrel and omeprazole.

Importantly, these differences are sufficient to change the sign of θik(t) and consequently the interpretation of the temporal sequence of events in cardiovascular interactions.

Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors.

The present review has aimed to emphasize on the potential effects of herbs on CVD and cardiovascular drug interactions.

Ethnic Differences in Cardiovascular-Somatosensory Interactions and in the Central Processing of Noxious Stimuli.

Obesity is known to be associated with cardiovascular disease and interaction between inflammation and insulin resistance is reported to enhance the cardiovascular risk in these subjects.

(i) The cardiovascular drug-target interaction.

For all the cardiovascular diseases an interaction with age was observed which appears to begin at the same age, two examples are shown in Figure  1.

CV: cardiovascular; DDI: drug drug interaction; HDL: high-density lipoprotein; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol; MetS: Metabolic syndrome T2D: type 2 diabetes.

In conclusion, these model-based analyses proved an efficient and effective way to synthesize complex, confounded clinical pharmacology information from early clinical data of LY2878735, thus helping elucidate the relative positioning of LY2878735 in the class of SNRIs with regard to relative SERT/NET potency, target engagement, and cardiovascular and drug interaction liabilities.

The network score for a protein is the amount of interactions to cardiovascular gene products out of all interaction partners of the protein, making networks consisting of proteins with many interactions less important and reducing noise from highly interacting proteins for non-cardiovascular proteins.